Atlas Trials

Comparison of Efficacy and Safety Psoralen Combined With Ultraviolet A (PUVA) Vs Tofacitinib in the Treatment of Generalized Vitiligo.

Clinical trial NCT07055529 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07055529
Sponsor
Hayat Abad Medical Complex, Peshawar
Status
NOT_YET_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Vitiligo, Generalized
Start date
2026-06-01
Primary completion
2026-12-31
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.